Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.41 |
| ▸ | TAS1R2 | Q8TE23 | 3/20 | 0.41 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 3/20 | 0.36 |
| ▸ | CNR2 | P34972 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22729496 | 1.00 | TAS1R3 (0.41) | TAS1R3TAS1R1TAS1R2SSTR4NPC1 | |
| SCHEMBL22729622 | 1.00 | TAS1R3 (0.41) | TAS1R3TAS1R1TAS1R2SSTR4NPC1 | |
| SCHEMBL22754977 | 0.98 | TAS1R3 (0.39) | TAS1R3TAS1R1TAS1R2SSTR4NPC1 | |
| SCHEMBL22729572 | 0.98 | TAS1R3 (0.39) | TAS1R3TAS1R1TAS1R2SSTR4NPC1 | |
| SCHEMBL22729570 | 0.98 | TAS1R3 (0.39) | TAS1R3TAS1R1TAS1R2SSTR4NPC1 | |
| SCHEMBL23139743 | 0.98 | TAS1R3 (0.39) | TAS1R3TAS1R1TAS1R2SSTR4NPC1 | |
| SCHEMBL22729738 | 0.98 | TAS1R3 (0.39) | TAS1R3TAS1R1TAS1R2SSTR4NPC1 | |
| SCHEMBL23116406 | 0.86 | ALDH1A1 (0.40) | TAS1R3TAS1R1TAS1R2NPC1RAB9A | |
| SCHEMBL23116405 | 0.86 | ALDH1A1 (0.40) | TAS1R3TAS1R1TAS1R2NPC1RAB9A | |
| SCHEMBL22729446 | 0.86 | ALDH1A1 (0.40) | TAS1R3TAS1R1TAS1R2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11459325-B2 | Heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2022-10-04 | — | — | US | disclosed |
| US-20210087186-A1 | HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2021-03-25 | — | — | US | disclosed |
| US-20210087186-A1 | HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2021-03-25 | — | — | US | disclosed |
| EP-3747885-A1 | HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2020-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210087186-A1 | HETEROCYCLIC COMPOUND | GBA1, GBA2, GALC | TAS1R3 3587/4885TAS1R1 3209/4885TAS1R2 2745/4885 |
| US-11459325-B2 | Heterocyclic compound | GBA1, GBA2, GALC | TAS1R3 3710/4885TAS1R1 3286/4885TAS1R2 2869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.